| Dr Alejandro Adolfo Robles Torres, MD | |
|
2475 W Atlantic Ave, Delray Beach, FL 33445-4425 | |
| (561) 501-5858 | |
| (561) 270-6941 |
| Full Name | Dr Alejandro Adolfo Robles Torres |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 2475 W Atlantic Ave, Delray Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194144667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | ME137087 (Florida) | Primary |
| Entity Name | Joseph L Morse Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740333244 PECOS PAC ID: 6800853706 Enrollment ID: O20041213000447 |
News Archive
Wellstar International Inc. has announced they will be installing a system in Beverly Hills, California.
Stanford University School of Medicine researchers have demonstrated that gene therapy can be effective without causing a dangerous side effect common to all gene therapy: an autoimmune reaction to the normal protein, which the patient's immune system is encountering for the first time.
Stryker Corporation's Orthopaedics Division today announced U.S. Food and Drug Administration 510(k) clearance for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System. MDM X3 is an addition to the company's portfolio of next-generation technologies designed to minimize the risks traditionally associated with hip replacement surgery and address a broader patient population, including both primary and revision total hip arthroplasty candidates.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alejandro Adolfo Robles Torres, MD 2475 W Atlantic Ave, Delray Beach, FL 33445-4425 Ph: (561) 501-5858 | Dr Alejandro Adolfo Robles Torres, MD 2475 W Atlantic Ave, Delray Beach, FL 33445-4425 Ph: (561) 501-5858 |
News Archive
Wellstar International Inc. has announced they will be installing a system in Beverly Hills, California.
Stanford University School of Medicine researchers have demonstrated that gene therapy can be effective without causing a dangerous side effect common to all gene therapy: an autoimmune reaction to the normal protein, which the patient's immune system is encountering for the first time.
Stryker Corporation's Orthopaedics Division today announced U.S. Food and Drug Administration 510(k) clearance for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System. MDM X3 is an addition to the company's portfolio of next-generation technologies designed to minimize the risks traditionally associated with hip replacement surgery and address a broader patient population, including both primary and revision total hip arthroplasty candidates.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
› Verified 9 days ago
Dr. Chelsea Chapkin Albanese, D.O. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 15340 S Jog Rd Ste 200, Delray Beach, FL 33446 Phone: 561-496-7200 | |
Dr. Alvin Gordon Beyerlein Jr., MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 15300 S Jog Rd Ste 205, Delray Beach, FL 33446 Phone: 561-493-7200 Fax: 561-496-7989 | |
Dr. Ahmet H Lavkan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4662 Hammock Cir, Delray Beach, FL 33445 Phone: 561-254-6464 | |
Marlon Amos Labi, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 13593 Barcelona Lake Cir, Delray Beach, FL 33446 Phone: 954-849-4953 | |
John Receveur, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2932 Sw 22nd Cir Apt B, Delray Beach, FL 33445 Phone: 302-507-4975 | |
Rodolfo Reyes, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N Congress Ave Ste 403, Delray Beach, FL 33445 Phone: 561-272-1618 Fax: 561-272-2880 | |
Marie Rubby Roger, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 13455 S Military Trl Ste A, Delray Beach, FL 33484 Phone: 561-288-6153 Fax: 561-288-6087 |